Giorgia Timon - Concepedia

Author

Giorgia Timon

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

Ciro Franzese, G Timon, G. Timon, Giorgia Timon, Patrizia Ciammella, Redona Tafili, Timon, Giorgia

Publications

584

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico European Institute of Oncology Azienda Sanitaria Unità Locale di Reggio Emilia University of Milan Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

About

Giorgia Timon is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in radiation oncology, medicine, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	235
2	Radiation Medicine	2	2	121
3	Health Sciences	1	1	18
4	Geriatrics	1	1	18
5	Surgical Oncology	1	1	76

Giorgia Timon

Publications

398

Citations

H-Index

Page 1

	Year	Citations
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study Cristina Masini, Cinzia Iotti, Ugo De Giorgi, European Urology Pretreated PatientsUrologyRadiation MedicineRadiation TherapyGenitourinary Cancer	2021	99
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes Barbara Alicja Jereczek‐Fossa, Giuseppe Fanetti, Cristiana Fodor, Clinical Genitourinary Cancer Consecutive PatientsSingle Institution SeriesUrologySurgical OncologyRadiation Therapy	2017	76
Radiomic Profiling of Head and Neck Cancer: <sup>18</sup>F-FDG PET Texture Analysis as Predictor of Patient Survival Giacomo Feliciani, Federica Fioroni, Elisa Grassi, Contrast Media & Molecular Imaging	2018	43
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group Ciro Franzese, Giulia Marvaso, Giulio Francolini, Clinical & Experimental Metastasis UrologyRadiation MedicineMetastatic Kidney CancerRadiation TherapyGenitourinary Cancer	2021	22
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, Journal of Nuclear Medicine	2024	21
Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer Salvatore Cozzi, A. Botti, Giorgia Timon, Strahlentherapie und Onkologie Prognostic FactorsUrologyRadiation TherapyMedicineBrachytherapy	2021	20
Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments D. Ciardo, Barbara Alicja Jereczek‐Fossa, Giuseppe Petralia, British Journal of Radiology	2017	19
Role of multidimensional assessment of frailty in predicting outcomes in older patients with glioblastoma treated with adjuvant concurrent chemo-radiation Lucia Giaccherini, M. Galaverni, Ilaria Renna, Journal of Geriatric Oncology Adaptive RadiotherapyNeuro-oncologyPrognostic EvaluationGeriatric OncologyHealth Sciences	2019	18
Rationale and Protocol of AIRC IG-13218, Short-Term Radiotherapy for Early Prostate Cancer with Concomitant Boost to the Dominant Lesion Giorgia Timon, D. Ciardo, Alessia Bazani, Tumori Journal	2016	16
Once-Weekly Stereotactic Radiotherapy for Patients with Oligometastases: Compliance and Preliminary Efficacy Renzo Corvò, Giorgio Lamanna, Stefano Vagge, Tumori Journal	2013	16

Page 1